ELIXIR-IT HPC@CINECA: high performance computing resources for the bioinformatics community.


Journal

BMC bioinformatics
ISSN: 1471-2105
Titre abrégé: BMC Bioinformatics
Pays: England
ID NLM: 100965194

Informations de publication

Date de publication:
21 Aug 2020
Historique:
entrez: 26 8 2020
pubmed: 26 8 2020
medline: 3 10 2020
Statut: epublish

Résumé

The advent of Next Generation Sequencing (NGS) technologies and the concomitant reduction in sequencing costs allows unprecedented high throughput profiling of biological systems in a cost-efficient manner. Modern biological experiments are increasingly becoming both data and computationally intensive and the wealth of publicly available biological data is introducing bioinformatics into the "Big Data" era. For these reasons, the effective application of High Performance Computing (HPC) architectures is becoming progressively more recognized also by bioinformaticians. Here we describe HPC resources provisioning pilot programs dedicated to bioinformaticians, run by the Italian Node of ELIXIR (ELIXIR-IT) in collaboration with CINECA, the main Italian supercomputing center. Starting from April 2016, CINECA and ELIXIR-IT launched the pilot Call "ELIXIR-IT HPC@CINECA", offering streamlined access to HPC resources for bioinformatics. Resources are made available either through web front-ends to dedicated workflows developed at CINECA or by providing direct access to the High Performance Computing systems through a standard command-line interface tailored for bioinformatics data analysis. This allows to offer to the biomedical research community a production scale environment, continuously updated with the latest available versions of publicly available reference datasets and bioinformatic tools. Currently, 63 research projects have gained access to the HPC@CINECA program, for a total handout of ~ 8 Millions of CPU/hours and, for data storage, ~ 100 TB of permanent and ~ 300 TB of temporary space. Three years after the beginning of the ELIXIR-IT HPC@CINECA program, we can appreciate its impact over the Italian bioinformatics community and draw some considerations. Several Italian researchers who applied to the program have gained access to one of the top-ranking public scientific supercomputing facilities in Europe. Those investigators had the opportunity to sensibly reduce computational turnaround times in their research projects and to process massive amounts of data, pursuing research approaches that would have been otherwise difficult or impossible to undertake. Moreover, by taking advantage of the wealth of documentation and training material provided by CINECA, participants had the opportunity to improve their skills in the usage of HPC systems and be better positioned to apply to similar EU programs of greater scale, such as PRACE. To illustrate the effective usage and impact of the resources awarded by the program - in different research applications - we report five successful use cases, which have already published their findings in peer-reviewed journals.

Sections du résumé

BACKGROUND BACKGROUND
The advent of Next Generation Sequencing (NGS) technologies and the concomitant reduction in sequencing costs allows unprecedented high throughput profiling of biological systems in a cost-efficient manner. Modern biological experiments are increasingly becoming both data and computationally intensive and the wealth of publicly available biological data is introducing bioinformatics into the "Big Data" era. For these reasons, the effective application of High Performance Computing (HPC) architectures is becoming progressively more recognized also by bioinformaticians. Here we describe HPC resources provisioning pilot programs dedicated to bioinformaticians, run by the Italian Node of ELIXIR (ELIXIR-IT) in collaboration with CINECA, the main Italian supercomputing center.
RESULTS RESULTS
Starting from April 2016, CINECA and ELIXIR-IT launched the pilot Call "ELIXIR-IT HPC@CINECA", offering streamlined access to HPC resources for bioinformatics. Resources are made available either through web front-ends to dedicated workflows developed at CINECA or by providing direct access to the High Performance Computing systems through a standard command-line interface tailored for bioinformatics data analysis. This allows to offer to the biomedical research community a production scale environment, continuously updated with the latest available versions of publicly available reference datasets and bioinformatic tools. Currently, 63 research projects have gained access to the HPC@CINECA program, for a total handout of ~ 8 Millions of CPU/hours and, for data storage, ~ 100 TB of permanent and ~ 300 TB of temporary space.
CONCLUSIONS CONCLUSIONS
Three years after the beginning of the ELIXIR-IT HPC@CINECA program, we can appreciate its impact over the Italian bioinformatics community and draw some considerations. Several Italian researchers who applied to the program have gained access to one of the top-ranking public scientific supercomputing facilities in Europe. Those investigators had the opportunity to sensibly reduce computational turnaround times in their research projects and to process massive amounts of data, pursuing research approaches that would have been otherwise difficult or impossible to undertake. Moreover, by taking advantage of the wealth of documentation and training material provided by CINECA, participants had the opportunity to improve their skills in the usage of HPC systems and be better positioned to apply to similar EU programs of greater scale, such as PRACE. To illustrate the effective usage and impact of the resources awarded by the program - in different research applications - we report five successful use cases, which have already published their findings in peer-reviewed journals.

Identifiants

pubmed: 32838759
doi: 10.1186/s12859-020-03565-8
pii: 10.1186/s12859-020-03565-8
pmc: PMC7446135
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

352

Références

PLoS Biol. 2015 Jul 07;13(7):e1002195
pubmed: 26151137
PLoS One. 2013 Sep 27;8(9):e75619
pubmed: 24086590
J Hered. 2009 Nov-Dec;100(6):659-74
pubmed: 19892720
Brief Bioinform. 2017 Mar 1;18(2):279-290
pubmed: 26979602
Plant Cell Physiol. 2018 Jan 1;59(1):e2
pubmed: 29216377
Mol Ecol. 2016 Aug;25(16):3865-83
pubmed: 27357267
Nucleic Acids Res. 2011 Jan;39(Database issue):D19-21
pubmed: 21062823
BMC Genomics. 2015;16:S3
pubmed: 26046471
Bioinformatics. 2013 Jul 15;29(14):1813-4
pubmed: 23742983
Brief Bioinform. 2019 Mar 22;20(2):436-447
pubmed: 29040360
Bioinformatics. 2010 Jul 15;26(14):1772-6
pubmed: 20547637
Gigascience. 2013 Jun 25;2(1):9
pubmed: 23800020
Bioinformatics. 2011 May 1;27(9):1311-2
pubmed: 21427194
BMC Genomics. 2018 Feb 5;19(1):120
pubmed: 29402227
Nucleic Acids Res. 2019 Jan 10;47(1):221-236
pubmed: 30462294
RNA Biol. 2006 Jan-Mar;3(1):1-9
pubmed: 17114938
Nat Rev Genet. 2016 May 17;17(6):333-51
pubmed: 27184599
Nat Rev Genet. 2009 Jan;10(1):57-63
pubmed: 19015660
Nat Immunol. 2017 Nov 16;18(12):1274-1278
pubmed: 29144493
Nature. 2013 Jun 13;498(7453):255-60
pubmed: 23765498
Gigascience. 2018 Oct 1;7(10):
pubmed: 29860514
Nat Methods. 2009 May;6(5):377-82
pubmed: 19349980
Mutat Res Rev Mutat Res. 2012 Jan 14;751(1):15-28
pubmed: 22266568
Gigascience. 2019 Jan 1;8(1):
pubmed: 30496513
FASEB J. 2003 Jul;17(10):1195-214
pubmed: 12832285

Auteurs

Tiziana Castrignanò (T)

Department of Ecological and Biological Sciences (DEB), University of Tuscia, Viterbo, Italy. tiziana.castrignano@unitus.it.

Silvia Gioiosa (S)

CINECA, SuperComputing Applications and Innovation Department, Rome, Italy.
Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (IBIOM-CNR), Bari, Italy.

Tiziano Flati (T)

CINECA, SuperComputing Applications and Innovation Department, Rome, Italy.
Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (IBIOM-CNR), Bari, Italy.

Mirko Cestari (M)

CINECA, SuperComputing Applications and Innovation Department, Rome, Italy.

Ernesto Picardi (E)

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (IBIOM-CNR), Bari, Italy.
Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari "A. Moro", Bari, Italy.

Matteo Chiara (M)

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (IBIOM-CNR), Bari, Italy.
Department of Biosciences, University of Milan, Milan, Italy.

Maddalena Fratelli (M)

IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Milano, Milan, Italy.

Stefano Amente (S)

Department of Molecular Medicine and Medical Biotechnologies, University of Naples 'Federico II', Naples, Italy.

Marco Cirilli (M)

Department of Agricultural and Environmental Sciences - Production, Landscape, Agroenergy (DISAA), University of Milan, Milan, Italy.

Marco Antonio Tangaro (MA)

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (IBIOM-CNR), Bari, Italy.

Giovanni Chillemi (G)

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (IBIOM-CNR), Bari, Italy.
Department for Innovation in Biological, Agro-food and Forest systems (DIBAF), University of Tuscia, Viterbo, Italy.

Graziano Pesole (G)

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (IBIOM-CNR), Bari, Italy. graziano.pesole@uniba.it.
Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari "A. Moro", Bari, Italy. graziano.pesole@uniba.it.

Federico Zambelli (F)

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (IBIOM-CNR), Bari, Italy. federico.zambelli@unimi.it.
Department of Biosciences, University of Milan, Milan, Italy. federico.zambelli@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH